PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW000709View Pathway |
Temocapril Metabolism PathwayHomo sapiens
Temocapril (trade name: Acecol) belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors and is used primarily to lower high blood pressure (hypertension). This drug can also be used in the treatment of congestive heart failure and type II diabetes. Temocapril is a prodrug which, following oral administration, undergoes biotransformation in vivo into its active form temocaprilat via cleavage of its ester group by the liver. Angiotensin-converting enzyme (ACE) is a component of the body's renin–angiotensin–aldosterone system (RAAS) and cleaves inactive angiotensin I into the active vasoconstrictor angiotensin II. ACE (or kininase II) also degrades the potent vasodilator bradykinin. Consequently, ACE inhibitors decrease angiotensin II concentrations and increase bradykinin concentrations resulting in blood vessel dilation and thereby lowering blood pressure.
|
Creator: WishartLab Created On: June 23, 2014 at 04:47 Last Updated: June 23, 2014 at 04:47 |
PW146518View Pathway |
drug action
Temocillin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:24 Last Updated: October 07, 2023 at 18:24 |
PW146408View Pathway |
drug action
Temoporfin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:07 Last Updated: October 07, 2023 at 18:07 |
PW128232View Pathway |
drug action
Temozolomide Action PathwayHomo sapiens
Temozolomide (TMZ) is an antineoplastic from the alkylating agent drug class. This molecule is an imidazotetrazine prodrug that is stable at acidic pH but undergoes spontaneous nonenzymatic hydrolysis at neutral or slightly basic pH; allowing its administration to be oral and intravenous too. Temozolomide is indicated in the treatment of newly diagnosed glioblastoma and refractory anaplastic astrocytoma. This molecule is a very small lipophilic, it can then easily get through the blood-brain barrier. The mechanism of action of this drug needs many reactions beforehand: TMZ undergoes spontaneous nonenzymatic breakdown at physiological pH to form 5-(3-methyltriazen-1-yl) imidazole-4-carboxamide (MTIC), which then reacts with water to produce 5-aminoimidazole-4-carboxamide (AIC) and a highly reactive methyl diazonium cation. TMZ is a bit specific to tumor cells because glioblastoma typically possesses a more alkaline pH than healthy tissue, favoring its activation in tumor cells. The methyl diazonium cation formed methylates DNA at the N7 and O6 position of guanine, and the N3 position of adenine. The cellular repair system will eventually lead to DNA strand breaks that will end in the apoptosis of the cell.
|
Creator: Daphnee Created On: August 04, 2023 at 13:55 Last Updated: August 04, 2023 at 13:55 |
PW144958View Pathway |
drug action
Temozolomide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:48 Last Updated: October 07, 2023 at 14:48 |
PW128248View Pathway |
Template for Biotech Drug MetabolismHomo sapiens
|
Creator: Selena Created On: August 09, 2023 at 15:44 Last Updated: August 09, 2023 at 15:44 |
PW128172View Pathway |
Template for Biotech Drug Metabolism Reticuloendothelial SystemHomo sapiens
|
Creator: Selena Created On: July 27, 2023 at 13:01 Last Updated: July 27, 2023 at 13:01 |
PW175941View Pathway |
Template Predicted Metabolism PathwayHomo sapiens
Template PIS1M1, Template PIS1M2, Template PIS1M3,Template PIS1M4, Template PIS2M1, Template PIS2M2, Template PIS2M3 are metabolites of Template predicted with biotransformer.
Template M1, Template M2, Template M3, Template M4, Template M5, Template M6, Template M7, Template M8, Template M9, Template M10, Template M11, Template M12, Template M13, Template M14, Template M15, Template M16, Template M17, Template M18 are metabolites of Template predicted with biotransformer.
|
Creator: Omolola Created On: November 16, 2023 at 14:31 Last Updated: November 16, 2023 at 14:31 |
PW176182View Pathway |
Template2M Predicted Metabolism PathwayHomo sapiens
Metabolites of Template2M are predicted with biotransformer.
|
Creator: Omolola Created On: December 04, 2023 at 10:31 Last Updated: December 04, 2023 at 10:31 |
PW176221View Pathway |
Template2MD Predicted Metabolism PathwayHomo sapiens
Metabolites of Template2MD are predicted with biotransformer.
|
Creator: Omolola Created On: December 04, 2023 at 12:52 Last Updated: December 04, 2023 at 12:52 |